Financial Partners Group, Inc Abiomed Inc Transaction History

Financial Partners Group, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$130.51 - $196.01 $288,296 - $432,986	-2,209 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$175.89 - $279.23 $127,520 - $202,441	-725 Reduced 24.71%	2,209 $393,000
Q2 2019 Aug 15, 2019	SELL	$250.96 - $284.94 $1,505 - $1,709	-6 Reduced 0.2%	2,934 $764,000
Q1 2019 May 07, 2019	BUY	$276.39 - $362.25 $8,568 - $11,229	31 Added 1.07%	2,940 $840,000
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $71,956 - $113,728	-256 Reduced 8.09%	2,909 $946,000

Q3 2018 Nov 02, 2018	BUY	$354.53 - $449.75 $195,700 - $248,262	552 Added 21.13%	3,165 $1.42 Million
Q2 2018 Aug 03, 2018	BUY	$278.07 - $446.21 $138,478 - $222,212	498 Added 23.55%	2,613 $1.07 Million
Q1 2018 May 11, 2018	BUY	$192.49 - $295.85 $407,116 - $625,722	2,115 New	2,115 $615,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Financial Partners Group, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Partners Group, Inc with notifications on news.